FindTrial
Sign In

Clinical Registration Study of Neuromyelitis Optica Spectrum Disorders Score

Clinical Registration Study of Neuromyelitis Optica Spectrum Disorders Score

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-POC-17014010
Enrollment
Unknown
Registered
2017-12-17
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NMOSD

Interventions

1:no

Sponsors

Department of Neurology of Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 99 Years

Inclusion criteria

Inclusion criteria: 1. patients in the Department of Neurology of Beijing Tongren Hospital, Capital Medical University were treated with visual loss and visual field defect as the main complaint during 2018.1-2022.1; 2. medical treatment within 2 months; 3. signing informed consent.

Exclusion criteria

Exclusion criteria: 1. other ophthalmologic diseases: retinopathy, glaucoma, preganglionic lesions, vineal lesions, vitreous lesions, and so on; 2. other optic neuropathy: oppressive, invasive, infectious, traumatic, toxic and nutritive, hereditary, etc.; 3. other intracranial lesions that cause loss of vision.

Design outcomes

Primary

MeasureTime frame
EDSS Score;NMO Severity Scale;—

Countries

China

Contacts

Public ContactJiawei Wang

Department of Neurology of Beijing Tongren Hospital, Capital Medical University

wangjwcq@163.com+86 13651110820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026